Methyl 2-((2-((3-(5-amino-6-(tert-butylcarbamoyl)-2-phenylthieno[2,3-d]pyrimidin-4-yl)phenyl)amino)-2-oxoethyl)amino)acetate

Catalog No. :
ACKEGS288
CAS No. :
501651-22-5
Molecular Formula :
C28H30N6O4S
Molecular Weight :
546.65

IUPAC Name:methyl (2-((3-(5-amino-6-(tert-butylcarbamoyl)-2-phenylthieno[2,3-d]pyrimidin-4-yl)phenyl)amino)-2-oxoethyl)glycinate

Methyl 2-((2-((3-(5-amino-6-(tert-butylcarbamoyl)-2-phenylthieno[2,3-d]pyrimidin-4-yl)phenyl)amino)-2-oxoethyl)amino)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-((2-((3-(5-amino-6-(tert-butylcarbamoyl)-2-phenylthieno[2,3-d]pyrimidin-4-yl)phenyl)amino)-2-oxoethyl)amino)acetate
IUPAC Namemethyl (2-((3-(5-amino-6-(tert-butylcarbamoyl)-2-phenylthieno[2,3-d]pyrimidin-4-yl)phenyl)amino)-2-oxoethyl)glycinate
Molecular FormulaC28H30N6O4S
Molecular Weight546.65
SMILESO=C(OC)CNCC(NC1=CC=CC(C2=C(C(N)=C(C(NC(C)(C)C)=O)S3)C3=NC(C4=CC=CC=C4)=N2)=C1)=O
InChI KeyLKXHLIZYDWBPIZ-UHFFFAOYSA-N
CAS No.501651-22-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKEGS288 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKEGS288 route product structure diagram
    ACKEGS288501651-22-5
Inquiry

2. ACKEGS288 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKEGS288 route product structure diagram
    ACKEGS288501651-22-5
Inquiry

Comments (0)